Equity Overview
Price & Market Data
Price: $0.627
Daily Change: $0.00 / 0.00%
Range: $0 - $0
Market Cap: $48,002,296
Volume: 0
Performance Metrics
1 Week: -15.28%
1 Month: -14.94%
3 Months: -9.71%
6 Months: 13.96%
1 Year: 80.43%
YTD: 57.83%
Details
Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company's products include LEGIO X COVID-19, a COVID-19 rapid antigen test; and LEGIO X Influenza AB, an influenza AB multiplex lateral flow test. It also develops respiratory syncytial virus and tuberculosis. Gemina Laboratories Ltd. was incorporated in 2017 and is headquartered in Burnaby, Canada.